Skip to main content
. 2016 Sep 22;34(41):4979–4984. doi: 10.1016/j.vaccine.2016.08.032

Table 4.

Factors associated with seroprevalence of anti-poliovirus type 3 antibodies by univariable, multivariable and multilevel multivariable logistic regression analysis among orally immunised Indian infants (N = 8454 for Unadjusted values except No. of OPV doses; N = 8449 for adjusted values since OPV status not available for 5 children).

Characteristic Standard univariable
Standard multivariable
Multilevel multivariable
HSC
PHC
Block
Odds Ratio (95% CI) p value Odds Ratio (95% CI) p value Odds Ratio (95% CI) p value Odds Ratio (95% CI) p value Odds Ratio (95% CI) p value
Sex
Male
1.24 (1.08–1.41) 0.002 1.27 (1.11–1.46) 0.001 1.27 (1.11–1.46) 0.001 1.27 (1.11–1.46) 0.001 1.27 (1.11–1.45) 0.001
Age in months 1.37 (1.31–1.43) <0.001 1.17 (1.12–1.23) <0.001 1.17 (1.12–1.23) <0.001 1.17 (1.12–1.23) <0.001 1.17 (1.12–1.23) <0.001
No. of tOPV doses 1.94 (1.80–2.09) <0.001 1.74 (1.61–1.89) <0.001 1.74 (1.60–1.89) <0.001 1.73 (1.59–1.88) <0.001 1.72 (1.58–1.87) <0.001
Area Urban 1.16 (0.99–1.36) 0.059 1.24 (1.05 –1.45) 0.010 1.24 (1.05– 1.46) 0.012 1.25 (1.05– 1.49) 0.013 1.18 (0.98–1.41) 0.087
Constant 0.0969128 0.0970927 0.0971074 0.1109489
−2Log Likelihood −2853.48 −2853.45 −2851.90 −2847.82
Chibar2(01) 0.06 3.16 11.33
Prob of Chibar2 > 0 0.4012 0.0376 0.0004

CI – Confidence Interval HSC – Health Sub-centre PHC – Primary Health Centre.